Patent assignee · FR · COMPANY

MNEMO THERAPEUTICS

1Patents
1Active
1Granted
51Portfolio score

Filing activity: May 12, 2023 → May 12, 2023

Most-cited patents

PatentTitleAreaCited byStatus
US12152077B1 Immunotherapy targeting tumor neoantigenic peptides Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.